Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pharma vs The IRA — Industry Leaders React To Merck Lawsuit

07 Jun 2023

• By Scrip Team

business people on the move — Which way will industry move after the Merck lawsuit? • Source: Shutterstock

Related Content

What Exactly Is A ‘Small Biotech’? US Medicare Agency Will Try To Spell It Out

17 Jan 2023

Dupixent Succeeds Where Other Biologic Drugs Failed – In COPD

23 Mar 2023

Medicare Price Negotiation: Special Treatment For ‘Novel Technologies’ On PhRMA’s Advocacy Agenda

08 Feb 2023

IRA Effect: Alnylam Acting ‘Rationally’ In Halting Second Orphan Indication For Amvuttra – Analysts

08 Nov 2022

Merck & Co. Files First IRA Suit, Signaling Industry Is Ready To Fight

06 Jun 2023

Related Companies

GSK plc

Merck & Co., Inc.

Sanofi

Regeneron Pharmaceuticals, Inc.

Nkarta, Inc.

Additional Topics

United States Pricing Debate Legal Issues Policy Politics Reimbursement BioPharmaceutical

More from Drug Pricing

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.